Sanofi’s Lantus Cuts Blood Sugar More Than Merck’s Januvia

Sanofi’s Lantus insulin reduced blood-sugar levels to a greater degree than Merck’s Januvia in people with Type 2 diabetes in a clinical trial.
The Wall Street Journal